Back to today’s briefing

Story perspectives

Duavee Drug Shows Promise Against Breast Cancer Risk

6/6/2025

43 9

Summary

Story summary

A groundbreaking trial at Northwestern University reveals that Duavee, a menopause medication, could significantly reduce the risk of invasive breast cancer in postmenopausal women with ductal carcinoma. Involving 141 participants, the study demonstrated decreased cell growth with minimal side effects, positioning Duavee as a promising and safe choice for managing menopausal symptoms while tackling breast cancer risks.

1 of 1

Story summary

A groundbreaking trial at Northwestern University reveals that Duavee, a menopause medication, could significantly reduce the risk of invasive breast cancer in postmenopausal women with ductal carcinoma. Involving 141 participants, the study demonstrated decreased cell growth with minimal side effects, positioning Duavee as a promising and safe choice for managing menopausal symptoms while tackling breast cancer risks.